SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

ABIONYX Pharma SA (ABNX.PA) News

Follow ABIONYX Pharma SA (ABNX.PA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ABNX.PA Asset equity Sector Markets 90 days 2 Last 1.56 Updated Oct 07, 2026, 06:51 AM UTC Open live news feed Open ABNX.PA chart & news
M ABIONYX Pharma and OLON enter strategic manufacturing partnership Abionyx Pharma SA announced a strategic manufacturing partnership with Olon to prepare its Cer-001 biologic for regulatory approval and commercial supply. Manufacturing will take place at two Olon sites in France. EQUITY | Oct 07, 2026, 06:51 AM UTC M ABIONYX Pharma and OLON partner for CER-001 biologic manufacturing ABIONYX Pharma announced a strategic manufacturing partnership with OLON to prepare its CER-001 biologic for regulatory approval and potential commercial supply. The collaboration will initially focus on producing two va EQUITY | Oct 07, 2026, 05:01 AM UTC